GSK rejects Unilever offers for Consumer Healthcare

17 January 2022 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK) has rejected three Unilever takeover offers for its Consumer Healthcare business, including one worth GBP50 billion (USD68 billion).

Click tags below for more information on topics:

GlaxoSmithKline Unilever

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: